SQ Innovation and FIS Announce Supply Agreement

SQ Innovation and FIS Fabbrica Italiana Sintetici S.p.A. have entered into a strategic supply agreement concerning Furosemide API. SQ Innovation, known for its development of Lasix® ONYU, will benefit from FIS's manufacturing capabilities for this critical pharmaceutical ingredient. This partnership aims to ensure a stable and reliable supply chain for the medication, which is essential for treating various medical conditions. The agreement underscores the importance of strategic collaborations in the pharmaceutical sector to maintain product availability and quality.